Adapting Dosing During Acute Illnesses Acute illnesses, such as infections or hospitalizations, add extra strain to already compromised kidneys
For laboratory and analytical research only
Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: involvement of the PI3K/Akt/GSK-3 pathway
Objection to advertising e-mails The use of contact data published within the framework of the imprint obligation to send advertising and information materials not explicitly requested is hereby prohibited
For clinically well defined, low risk tumours that are less than 2 cm in diameter, a 4 mm margin of unaffected tissue around the tumour is sufficient to completely remove 95% of all primary SCCs
What You Need to Know Introduction Starting a weight loss journey with a GLP-1 medication often brings a mix of excitement and a long list of questions